- $22.92bn
- $24.70bn
- $16.62bn
- 53
- 88
- 96
- 93
Annual balance sheet for Markel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-Q | 10-Q | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Net Property, Plant And Equipment | 1,160 | — | — | 1,929 | 2,081 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Insurance Receivables | |||||
Other Long Term Assets | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 41,710 | 48,477 | 49,791 | 55,046 | 61,898 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 28,910 | 33,760 | 36,640 | 40,062 | 44,982 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 12,800 | 14,717 | 13,151 | 14,984 | 16,916 |
Total Liabilities & Shareholders' Equity | 41,710 | 48,477 | 49,791 | 55,046 | 61,898 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |